LMNB1
Basic information
Region (hg38): 5:126776623-126837020
Links
Phenotypes
GenCC
Source:
- microcephaly (Strong), mode of inheritance: AD
- adult-onset autosomal dominant demyelinating leukodystrophy (Limited), mode of inheritance: AD
- autosomal dominant primary microcephaly (Supportive), mode of inheritance: AD
- adult-onset autosomal dominant demyelinating leukodystrophy (Supportive), mode of inheritance: AD
- adult-onset autosomal dominant demyelinating leukodystrophy (Strong), mode of inheritance: AD
- microcephaly 26, primary, autosomal dominant (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Leukodystrophy, demyelinating, adult-onset, autosomal dominant; Microcephaly 26, primary, autosomal dominant | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 16951681; 19151023; 21225301; 21909802; 23243074; 23649844; 32910914; 33033404 |
ClinVar
This is a list of variants' phenotypes submitted to
- Microcephaly 26, primary, autosomal dominant (3 variants)
- Syndrome with microcephaly as major feature (3 variants)
- Inborn genetic diseases (2 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LMNB1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 23 | 13 | 38 | |||
missense | 88 | 102 | ||||
nonsense | 2 | |||||
start loss | 1 | |||||
frameshift | 3 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 4 | 8 | 1 | 13 | ||
non coding | 19 | 14 | 22 | 55 | ||
Total | 3 | 1 | 118 | 45 | 39 |
Variants in LMNB1
This is a list of pathogenic ClinVar variants found in the LMNB1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-126776801-G-C | Leukodystrophy, Adult-Onset | Uncertain significance (Jun 14, 2016) | ||
5-126776804-G-T | Leukodystrophy, Adult-Onset | Uncertain significance (Jun 14, 2016) | ||
5-126776808-C-T | Leukodystrophy, Adult-Onset | Uncertain significance (Jun 14, 2016) | ||
5-126776821-G-A | Leukodystrophy, Adult-Onset | Uncertain significance (Jun 14, 2016) | ||
5-126776874-T-C | Leukodystrophy, Adult-Onset | Likely benign (Jun 14, 2016) | ||
5-126776888-T-C | Leukodystrophy, Adult-Onset | Benign (Jun 14, 2016) | ||
5-126776914-G-A | Leukodystrophy, Adult-Onset | Likely benign (Jun 14, 2016) | ||
5-126776926-G-C | Leukodystrophy, Adult-Onset | Conflicting classifications of pathogenicity (Oct 01, 2022) | ||
5-126776932-C-T | Leukodystrophy, Adult-Onset | Likely benign (Jun 14, 2016) | ||
5-126776957-G-A | Leukodystrophy, Adult-Onset | Uncertain significance (Jun 14, 2016) | ||
5-126776969-G-A | Leukodystrophy, Adult-Onset | Uncertain significance (Jun 14, 2016) | ||
5-126777018-T-C | Leukodystrophy, Adult-Onset | Likely benign (Jun 14, 2016) | ||
5-126777072-C-G | Leukodystrophy, Adult-Onset | Uncertain significance (Jun 14, 2016) | ||
5-126777127-C-G | Leukodystrophy, Adult-Onset | Uncertain significance (Jun 14, 2016) | ||
5-126777195-C-T | Adult-onset autosomal dominant demyelinating leukodystrophy | Benign (Jan 13, 2018) | ||
5-126777211-G-T | Adult-onset autosomal dominant demyelinating leukodystrophy | Benign (Jan 12, 2018) | ||
5-126777350-C-G | Adult-onset autosomal dominant demyelinating leukodystrophy | Uncertain significance (Jan 13, 2018) | ||
5-126777433-G-T | Adult-onset autosomal dominant demyelinating leukodystrophy | Uncertain significance (Jan 13, 2018) | ||
5-126777509-A-G | Uncertain significance (Jan 18, 2022) | |||
5-126777521-A-G | Uncertain significance (May 21, 2021) | |||
5-126777523-C-T | Likely benign (Oct 07, 2022) | |||
5-126777524-C-T | Inborn genetic diseases | Conflicting classifications of pathogenicity (Jan 13, 2023) | ||
5-126777526-C-T | Likely benign (Jan 13, 2023) | |||
5-126777531-C-A | Inborn genetic diseases | Uncertain significance (Jan 23, 2024) | ||
5-126777537-G-T | LMNB1-related disorder | Benign (Nov 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LMNB1 | protein_coding | protein_coding | ENST00000261366 | 11 | 60398 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.555 | 0.445 | 125735 | 0 | 10 | 125745 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.63 | 229 | 310 | 0.740 | 0.0000166 | 3811 |
Missense in Polyphen | 40 | 72.957 | 0.54826 | 1019 | ||
Synonymous | 0.414 | 108 | 114 | 0.951 | 0.00000595 | 1114 |
Loss of Function | 3.92 | 6 | 28.6 | 0.210 | 0.00000136 | 371 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000579 | 0.0000579 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000619 | 0.0000615 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin.;
- Disease
- DISEASE: Leukodystrophy, demyelinating, autosomal dominant, adult- onset (ADLD) [MIM:169500]: A slowly progressive and fatal demyelinating leukodystrophy, presenting in the fourth or fifth decade of life. Clinically characterized by early autonomic abnormalities, pyramidal and cerebellar dysfunction, and symmetric demyelination of the CNS. It differs from multiple sclerosis and other demyelinating disorders in that neuropathology shows preservation of oligodendroglia in the presence of subtotal demyelination and lack of astrogliosis. {ECO:0000269|PubMed:16951681}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Apoptosis - Homo sapiens (human);Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer,s disease models;Neurodegenerative Diseases;Disease;tnfr1 signaling pathway;caspase cascade in apoptosis;hiv-1 nef: negative effector of fas and tnf;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Cellular Senescence;Cellular responses to stress;Breakdown of the nuclear lamina;Apoptotic cleavage of cellular proteins;Apoptotic execution phase;Apoptosis;Programmed Cell Death;Cellular responses to external stimuli;Depolymerisation of the Nuclear Lamina;Nuclear Envelope Breakdown;Mitotic Prophase;Initiation of Nuclear Envelope Reformation;Nuclear Envelope Reassembly;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic;Caspase Cascade in Apoptosis
(Consensus)
Recessive Scores
- pRec
- 0.521
Intolerance Scores
- loftool
- 0.181
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.53
Haploinsufficiency Scores
- pHI
- 0.932
- hipred
- Y
- hipred_score
- 0.739
- ghis
- 0.611
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.889
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lmnb1
- Phenotype
- skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; respiratory system phenotype; embryo phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; muscle phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- interleukin-12-mediated signaling pathway
- Cellular component
- nucleus;nuclear envelope;nuclear inner membrane;lamin filament;nucleoplasm;membrane;nuclear matrix;nuclear membrane
- Molecular function
- structural molecule activity;protein binding;phospholipase binding;sequence-specific double-stranded DNA binding